Dattoli Cancer CenterBrachytherapy Research Institute · Sarasota, Florida

A uniquely individualized radiation therapy treatment plan to defeat prostate cancer and preserve the quality of life.

Dattoli Cancer Center & Brachytherapy Research Institute in Sarasota Florida. We provide the highest level of personal attention possible.

About the Center

The Center

Dattoli Cancer Center was founded in 2001 by Michael Dattoli, MD, and Richard Sorace, MD, Ph.D. who had been in practice together in Tampa for nearly a decade. It was their dream to create a true state-of-the-art cancer center specifically for the non-surgical treatment of prostate cancer. In leaving Tampa, they put their heads and hearts on the line to make this dream a reality.

This Center would encompass all the latest technology for diagnosing prostate cancer and for treating it non-surgically and would become an incubator for research and technical design. The breadth of experience and the unmatched proficiency of these two radiation oncologists at work in this progressive environment fueled the Center’s rapid acceptance and widespread reputation.

Today the flow of patients to the Dattoli Cancer Center from all over the globe is a testament to the hard work and forward-thinking of Drs. Dattoli and Sorace since the founding of this remarkable Center.

What the Center does

01

Non-surgical prostate cancer treatment

A centre created specifically for the non-surgical treatment of prostate cancer, encompassing all the latest technology for diagnosing prostate cancer and for treating it non-surgically.

About the Center

02

Brachytherapy design

Well over two decades of brachytherapy experience and thousands of prostate implant procedures, optimizing brachytherapy designs to maximize tumor eradication and minimize symptoms.

Pioneer in treatments

From the Blog

Increasing Speed of Treatment Planning Systems and the Integration of AI

As the adoption of AI continues to accelerate, several challenges remain. To overcome these challenges, organizations need to reach digital maturity. That means developing robust governance and data maintenance processes. Moreover, they must implement modern software disciplines like Agile and DevOps. In addition, the ‘last mile’ problem is a significant hurdle from a scale perspective. […]

The Future of Radiation Therapy for Bladder Cancer

Future studies will examine potential markers of tumors, including a protein called MRE11, which plays a vital role in the cellular response to DNA damage induced by radiation. These findings could help doctors design strategies that preserve the bladder after radiation therapy. This will be especially useful for patients because removing the bladder can have […]

Radiation Oncology — Trends to Improve Radiotherapy

Multidisciplinary treatment is evolving from a series of isolated procedures to an integrated approach that combines radiation oncology, medical oncology, and allied health services. This interdisciplinary approach considers treatment options, establishes a treatment plan, and provides supportive care. As a result, radiation oncology centers are gaining more expertise in particular techniques and malignancies. They are […]

Programming for Off-Line Adaptive Radiotherapy

The main difference between real-time and off-line image-guided adaptive radiotherapy is that the latter relies on software to control radiation therapy. For example, real-time image-guided adaptive radiotherapy will require a more sophisticated model that will have stopping rules to pause treatment when the deviation from the treatment plan reaches a certain threshold. Aside from the […]

Adaptive Planning Method for Radiation Therapy

According to Dattoli Cancer Center, traditional treatment planning involves many manual processes. The optimal dose distribution must be determined for every patient. This optimal dose distribution never exists a priori, and planners must negotiate multiple competing parameters in a trial-and-error process. Optimization processes iteratively optimize clinical and dosimetric objectives. […]

Testosterone: Friend or Foe?

Perhaps one of the most controversial subjects in the prostate cancer world is the role of testosterone — its influence on the development of prostate cancer, its impact on current tumor growth, and more recently its possible ability to slow […]

All entries